# The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery

Study · id `cardio:ct-nct05006287` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05006287](<https://clinicaltrials.gov/study/NCT05006287>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05006287

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 100 participants.

## Technical summary

Registry record NCT05006287. Randomized; no masking; primary purpose treatment. Start 2022-10-12 (actual); primary completion 2024-05-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT05006287, source copy `cardio:ctgov-nct05006287-2024-04-17`, retrieved 2026-10-26)
- Started: 2022-10-12 (actual) (ClinicalTrials.gov record NCT05006287, source copy `cardio:ctgov-nct05006287-2024-04-17`, retrieved 2026-10-26)
- Primary completion: 2024-05-30 (anticipated) (ClinicalTrials.gov record NCT05006287, source copy `cardio:ctgov-nct05006287-2024-04-17`, retrieved 2026-10-26)
- Completion: 2024-05-30 (anticipated) (ClinicalTrials.gov record NCT05006287, source copy `cardio:ctgov-nct05006287-2024-04-17`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT05006287, source copy `cardio:ctgov-nct05006287-2024-04-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05006287-2024-04-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery
- Condition: Atrial Fibrillation
- Intervention (Drug): Non-vitamin K oral anticoagulants (NOACs)
- Intervention (Drug): Warfarin
- Lead sponsor: St. Paul's Hospital, Canada
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry intervention name matches this record: Warfarin (`core:warfarin`)

## Provenance

Content hash: c5dc1f0194a018438041275df4446ad52e39caefb39637bda2710265f3822d56
Last substantive edit: 2026-10-30
Evidence last checked: Not recorded
